Ras signaling in aging and metabolic regulation

Nutrition and Healthy Aging

Volumn 4, Issue 3, 2017, Pages 195-205

  Slack, Cathy ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

aging; Lifespan; metabolism; Ras signaling

Indexed keywords

EID: 85044460121     PISSN: 24519480     EISSN: 24519502     Source Type: Journal    
DOI: 10.3233/NHA-160021     Document Type: Review

References (103)

1. Blokh D, Stambler I. Information theoretical analysis of aging as a risk factor for heart disease. Aging and Disease. 2015;6(3):196-207.
2. Niccoli T, Partridge L. Ageing as a risk factor for disease. Current Biology. 2012;22(17):R741-52.
3. Pike CJ. Sex and the development of Alzheimer's disease. Journal of Neuroscience Research. 2017;95(1-2):671-80.
4. van der Ende MY, Hartman MH, Hagemeijer Y, Meems LM, de Vries HS, Stolk RP, et al. The lifelines cohort study: Prevalence and treatment of cardiovascular disease and risk factors. International Journal of Cardiology. 2016;228:495-500.
5. White MC, Holman DM, Boehm JE, Peipins LA, Grossman M, Henley SJ. Age and cancer risk: A potentially modifiable relationship. American Journal of Preventive Medicine. 2014;46:S7-15.
6. Lopez-Otin C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 2013;153(6):1194-217.
7. Fontana L, Partridge L, Longo VD. Extending healthy life span-from yeast to humans. Science. 2010;328(5976): 321-6.
8. Partridge L, Alic N, Bjedov I, Piper MD. Ageing in Drosophila: The role of the insulin/Igf and TOR signalling network. Exp Gerontol. 2011;46(5):376-81.
9. Santos J, Leitao-Correia F, Sousa MJ, Leao C. Dietary restriction and nutrient balance in aging. Oxidative Medicine and Cellular Longevity. 2016;2016:10.
10. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A, et al. Mechanisms of life span extension by rapamycin in the fruit fly Drosophila melanogaster. Cell Metabolism. 2010;11(1):35-46.
11. Flynn JM, O'Leary MN, Zambataro CA, Academia EC, Presley MP, Garrett BJ, et al. Late-life rapamycin treatment reverses age-related heart dysfunction. Aging Cell. 2013;12(5):851-62.
12. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009;460(7253):392-5.
13. Majumder S, Caccamo A, Medina DX, Benavides AD, Javors MA, Kraig E, et al. Lifelong rapamycin administration ameliorates age-dependent cognitive deficits by reducing IL-1beta and enhancing NMDA signaling. Aging Cell. 2012;11(2):326-35.
14. Wilkinson JE, Burmeister L, Brooks SV, Chan CC, Friedline S, Harrison DE, et al. Rapamycin slows aging in mice. Aging Cell. 2012;11(4):675-82.
15. Mannick JB, Del Giudice G, Lattanzi M, Valiante NM, Praestgaard J, Huang B, et al. mTOR inhibition improves immune function in the elderly. Sci Transl Med. 2014;6(268):268ra179.
16. Borras C, Monleon D, Lopez-Grueso R, Gambini J, Orlando L, Pallardo FV, et al. RasGrf1 deficiency delays aging in mice. Aging. 2011;3(3):262-76.
17. Slack C, Alic N, Foley A, Cabecinha M, Hoddinott MP, Partridge L. The Ras-ERK-ETS-signaling pathway is a drug target for longevity. Cell. 2015;162(1):72-83.
18. McKay MM, Morrison DK. Integrating signals from RTKs to ERK/MAPK. Oncogene. 2007;26(22):3113-21.
19. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103(2):211-25.
20. Goitre L, Trapani E, Trabalzini L, Retta SF. The Ras superfamily of small GTPases: The unlocked secrets. Methods in Molecular Biology. 2014;1120:1-18.
21. Rajalingam K, Schreck R, Rapp UR, Albert S. Ras oncogenes and their downstream targets. Biochimica et Biphysica Acta. 2007;1773(8):1177-95.
22. Wittinghofer A, Nassar N. How Ras-related proteins talk to their effectors. Trends in Biochemical Sciences. 1996;21(12):488-91.
23. Barbacid M. ras genes. Annual Review of Biochemistry. 1987;56:779-827.
24. Mendoza MC, Er EE, Blenis J. The Ras-ERK and PI3KmTOR pathways: Cross-talk and compensation. Trends in Biochemical Sciences. 2011;36(6):320-8.
25. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EWT, Chang F, et al. Roles of the RAF/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochimica et Biophysica Acta. 2007;1773(8):1263-84.
26. Jazwinski SM. The RAS genes: A homeostatic device in Saccharomyces cerevisiae longevity. Neurobiology of Aging. 1999;20(5):471-8.
27. Fabrizio P, Liou LL, Moy VN, Diaspro A, Valentine JS, Gralla EB, et al. SOD2 functions downstream of Sch9 to extend longevity in yeast. Genetics. 2003;163(1):35-46.
28. Sun J, Kale SP, Childress AM, Pinswasdi C, Jazwinski SM. Divergent roles of RAS1 and RAS2 in yeast longevity. The Journal of Biological Chemistry. 1994;269(28):18638-45.
29. Fabrizio P, Pozza F, Pletcher SD, Gendron CM, Longo VD. Regulation of longevity and stress resistance by Sch9 in yeast. Science. 2001;292(5515):288-90.
30. Fabrizio P, Pletcher SD, Minois N, Vaupel JW, Longo VD. Chronological aging-independent replicative life span regulation by Msn2/Msn4 and Sod2 in Saccharomyces cerevisiae. FEBS Lett. 2004;557(1-3):136-42.
31. Lin SJ, Defossez PA, Guarente L. Requirement of NAD and SIR2 for life-span extension by calorie restriction in Saccharomyces cerevisiae. Science. 2000;289(5487): 2126-8.
32. Medvedik O, Lamming DW, Kim KD, Sinclair DA. MSN2 and MSN4 link calorie restriction and TOR to sirtuinmediated lifespan extension in Saccharomyces cerevisiae. PLoS Biology. 2007;5(10):e261.
33. Delaney JR, Murakami C, Chou A, Carr D, Schleit J, Sutphin GL, et al. Dietary restriction and mitochondrial function link replicative and chronological aging in Saccharomyces cerevisiae. Exp Gerontol. 2013;48(10):1006-13.
34. Altschuler DL, Muro A, Schijman A, Almonacid FB,Torres HN. Neurospora crassa cDNA clones coding for a new member of the ras protein family. FEBS Lett. 1990;273(1-2):103-6.
35. Kana-uchi A, Yamashiro CT, Tanabe S, Murayama T. A ras homologue of Neurospora crassa regulates morphology. Molecular & General Genetics. 1997;254(4):427-32.
36. Borkovich KA, Alex LA, Yarden O, Freitag M, Turner GE, Read ND, et al. Lessons from the genome sequence of Neurospora crassa: Tracing the path from genomic blueprint to multicellular organism. Microbiology and Molecular Biology Reviews. 68(1):1-108.
37. Belden WJ, Larrondo LF, Froehlich AC, Shi M, Chen CH, Loros JJ, et al. The band mutation in Neurospora crassa is a dominant allele of ras-1 implicating RAS signaling in circadian output. Genes Dev. 2007;21(12):1494-505.
38. Milburn MV, Tong L, deVos AM, Brunger A, Yamaizumi Z, Nishimura S, et al. Molecular switch for signal transduction: Structural differences between active and inactive forms of protooncogenic RAS proteins. Science. 1990;247(4945):939-45.
39. Segal M, Marbach I, Willumsen BM, Levitzki A. Two distinct regions of Ras participate in functional interaction with GDP-GTP exchangers. European Journal of Biochemistry. 1995;228(1):96-101.
40. Case ME, Griffith J, Dong W, Tigner IL, Gaines K, Jiang JC, et al. The aging biological clock in Neurospora crassa. Ecology and evolution. 2014;4(17):3494-507.
41. Brunner D, Ducker K, Oellers N, Hafen E, Scholz H, Klambt C. The ETS domain protein pointed-P2 is a target of MAP kinase in the sevenless signal transduction pathway. Nature. 1994;370(6488):386-9.
42. Halfon MS, Carmena A, Gisselbrecht S, Sackerson CM, Jimenez F, Baylies MK, et al. Ras pathway specificity is determined by the integration of multiple signalactivated and tissue-restricted transcription factors. Cell. 2000;103(1):63-74.
43. O'Neill EM, Rebay I, Tjian R, Rubin GM. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell. 1994;78(1):137-47.
44. Alic N, Giannakou ME, Papatheodorou I, Hoddinott MP, Andrews TD, Bolukbasi E, et al. Interplay of dFOXO and two ETS-family transcription factors determines lifespan in Drosophila melanogaster. PLoS Genetics. 2014;10(9):e1004619.
45. Sternberg PW, Han M. Genetics of RAS signaling in C. elegans. Trends Genet. 1998;14(11):466-72.
46. Tan PB, Lackner MR, Kim SK. MAP kinase signaling specificity mediated by the LIN-1 Ets/LIN-31 WH transcription factor complex during C. elegans vulval induction. Cell. 1998;93(4):569-80.
47. Nanji M, Hopper NA, Gems D. LET-60 RAS modulates effects of insulin/IGF-1 signaling on development and aging in Caenorhabditis elegans. Aging Cell. 2005;4(5):235-45.
48. Thyagarajan B, Blaszczak AG, Chandler KJ, Watts JL, Johnson WE, Graves BJ. ETS-4 is a transcriptional regulator of life span in Caenorhabditis elegans. PLoS Genetics. 2010;6(9):e1001125.
49. Umanoff H, Edelmann W, Pellicer A, Kucherlapati R. The murine N-RAS gene is not essential for growth and development. Proceedings of the National Academy of Sciences. 1995;92(5):1709-13.
50. Ise K, Nakamura K, Nakao K, Shimizu S, Harada H, Ichise T, et al. Targeted deletion of the H-ras gene decreases tumor formation in mouse skin carcinogenesis. Oncogene. 2000;19(26):2951-6.
51. Plowman SJ, Williamson DJ, O'Sullivan MJ, Doig J, Ritchie AM, Harrison DJ, et al. While K-ras is essential for mouse development, expression of the K-ras 4A splice variant is dispensable. Molecular and Cellular Biology. 2003;23(24):9245-50.
52. Plowman SJ, Arends MJ, Brownstein DG, Luo F, Devenney PS, Rose L, et al. The K-Ras 4A isoform promotes apoptosis but does not affect either lifespan or spontaneous tumor incidence in aging mice. Experimental Cell Research. 2006;312(1):16-26.
53. Elbourkadi N, Austad SN, Miller RA. Fibroblasts from long-lived species of mammals and birds show delayed, but prolonged, phosphorylation of ERK. Aging Cell. 2014;13(2):283-91.
54. Sun LY, Steinbaugh MJ, Masternak MM, Bartke A, Miller RA. Fibroblasts from long-lived mutant mice show diminished ERK1/2 phosphorylation but exaggerated induction of immediate early genes. Free Radical Biology & Medicine. 2009;47(12):1753-61.
55. Migliaccio E, Giorgio M, Mele S, Pelicci G, Reboldi P, Pandolfi PP, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature. 1999;402(6759):309-13.
56. Migliaccio E, Mele S, Salcini AE, Pelicci G, Lai KM, Superti-Furga G, et al. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. The EMBO Journal. 1997;16(4):706-16.
57. Ramsey JJ, Tran D, Giorgio M, Griffey SM, Koehne A, Laing ST, et al. The influence of Shc proteins on life span in mice. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2014;69(10): 1177-85.
58. Ratajczak MZ, Kucia M, Liu R, Shin DM, Bryndza E, Masternak MM, et al. RasGrf1: Genomic imprinting, VSELs, and aging. Aging. 2011;3(7):692-7.
59. Fernandez-Medarde A, Santos E. The RasGrf family of mammalian guanine nucleotide exchange factors. Biochimica et Biophysica Acta. 2011;1815(2):170-88.
60. Mirisola MG, Longo VD. Conserved role of Ras-GEFs in promoting aging: From yeast to mice. Aging. 2011;3(4): 340-3.
61. Rauen KA. HRAS and the Costello syndrome. Clinical Genetics. 2007;71(2):101-8.
62. Bonafe M, Barbi C, Olivieri F, Yashin A, Andreev KF, Vaupel JW, et al. An allele of HRAS1 3'variable number of tandem repeats is a frailty allele: Implication for an evolutionarily-conserved pathway involved in longevity. Gene. 2002;286(1):121-6.
63. Jazwinski SM, Kim S, Dai J, Li L, Bi X, Jiang JC, et al. HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell. 2010;9(5):698-708.
64. Aliper AM, Csoka AB, Buzdin A, Jetka T, Roumiantsev S, Moskalev A and Zhavoronkov A. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells. Aging. 2015;7(1):26-37.
65. WeiM, Fabrizio P,HuJ,GeH, Cheng C, Li L, et al. Life span extension by calorie restriction depends on rim15 and transcription factors downstream of Ras/PKA, tor, and Sch9. PLoS Genetics. 2008;4(1):e13.
66. Xie L, Jiang Y, Ouyang P, Chen J, Doan H, Herndon B, et al. Effects of dietary calorie restriction or exercise on the PI3K and Ras signaling pathways in the skin of mice. The Journal of Biological Chemistry. 2007;282(38): 28025-35.
67. Li Y, Daniel M, Tollefsbol TO. Epigenetic regulation of caloric restriction in aging. BMC Medicine. 2011;9(1):98.
68. Liu Y, Duysen E, Yaktine AL, Au A, Wang W, Birt DF. Dietary energy restriction inhibits ERK but not JNK or p38 activity in the epidermis ofSENCARmice. Carcinogenesis. 2001;22(4):607-12.
69. White MF. The insulin signalling system and the IRS proteins. Diabetologia. 1997;40(2):S2-S17.
70. Kenyon C. The first long-lived mutants: Discovery of the insulin/IGF-1 pathway for ageing. Philosophical Transactions of the Royal Society of London Series B, Biological Sciences. 2011;366(1561):9-16.
71. Castellano E, Downward J. RAS interaction with PI3K: More than just another effector pathway. Genes & Cancer. 2011;2(3):261-74.
72. Orme MH, Alrubaie S, Bradley GL, Walker CD, Leevers SJ. Input from Ras is required for maximal PI(3)K signalling in Drosophila. Nature Cell Biology. 2006;8(11): 1298-302.
73. Yang J-Y, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nature Cell Biology. 2008;10(2):138-48.
74. Zimmermann S, Moelling K. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science. 1999;286(5445):1741-4.
75. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, et al. Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice. The Journals of Gerontology Series A, Biological Sciences and Medical Sciences. 2011;66(2):191-201.
76. Kennedy BK, Lamming DW. The mechanistic target of rapamycin: The grand conducTOR of metabolism and aging. Cell metabolism. 2016;23(6):990-1003.
77. Carriere A, Romeo Y, Acosta-Jaquez HA, Moreau J, Bonneil E, Thibault P, et al. ERK1/2 phosphorylate raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1). Journal of Biological Chemistry. 2011;286(1):567-77.
78. Ma L, Chen Z, Erdjument-Bromage H, Tempst P, Pandolfi PP. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell. 2005;121(2):179-93.
79. Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Research Reviews. 2012;11(2):230-41.
80. Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R. The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes & Development. 2004;18(24):3004-9.
81. Curtis R, O'Connor G, DiStefano PS. Aging networks in Caenorhabditis elegans: AMP-activated protein kinase (aak-2) links multiple aging and metabolism pathways. Aging Cell. 2006;5(2):119-26.
82. Funakoshi M, Tsuda M, Muramatsu K, Hatsuda H, Morishita S, Aigaki T. A gain-of-function screen identifies wdb and lkb1 as lifespan-extending genes in Drosophila. Biochemical and Biophysical Research Communications. 2011;405(4):667-72.
83. Lopez-Cotarelo P, Escribano-Diaz C, Gonzalez-Bethencourt IL, Gomez-Moreira C, Deguiz ML, Torres-Bacete J, et al. A novel MEK-ERK-AMPK signaling axis controls chemokine receptor CCR7-dependent survival in human mature dendritic cells. The Journal of Biological Chemistry. 2015;290(2):827-40.
84. Kodiha M, Rassi JG, Brown CM, Stochaj U. Localization of AMP kinase is regulated by stress, cell density, and signaling through the MEK-ERK1/2 pathway. American Journal of Physiology-Cell Physiology. 2007;293(5):C1427-36.
85. Costanzo-Garvey DL, Pfluger PT, Dougherty MK, Stock JL, Boehm M, Chaika O, et al. KSR2 Is an Essential Regulator of AMP Kinase, Energy Expenditure, and Insulin Sensitivity. Cell Metabolism. 2009;10(5):366-78.
86. van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509(7501):439-46.
87. Campisi J. Aging, cellular senescence, and cancer. Annu Rev Physiol. 2013;75:685-705.
88. Jeyapalan JC, Sedivy JM. Cellular senescence and organismal aging. Mech Ageing Dev. 2008;129(7-8):467-74.
89. Naylor RM, Baker DJ, van Deursen JM. Senescent cells: A novel therapeutic target for aging and age-related diseases. Clin Pharmacol Ther. 2013;93(1):105-16.
90. Baker DJ,Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479(7372):232-6.
91. Dimauro T, David G. Ras-induced senescence and its physiological relevance in cancer. Curr Cancer Drug Targets. 2010;10(8):869-76.
92. Williamson D, Gallagher P, Harber M, Hollon C, Trappe S. Mitogen-activated protein kinase (MAPK) pathway activation: Effects of age and acute exercise on human skeletal muscle. J Physiol. 2003;547(Pt 3):977-87.
93. Foukas LC, Bilanges B, Bettedi L, Pearce W, Ali K, Sancho S, et al. Long-term p110alpha PI3K inactivation exerts a beneficial effect on metabolism. EMBO Mol Med. 2013;5(4):563-71.
94. Ortega-Molina A, Efeyan A, Lopez-Guadamillas E, Munoz-Martin M, Gomez-Lopez G, Canamero M, et al. Pten positively regulates brown adipose function, energy expenditure, and longevity. Cell metabolism. 2012;15(3):382-94.
95. Matheu A, MaraverA, Collado M, Garcia-Cao I, Canamero M, Borras C, et al. Anti-aging activity of the Ink4/Arf locus. Aging Cell. 2009;8(2):152-61.
96. Hofmann JW, Zhao X, De Cecco M, Peterson AL, Pagliaroli L, Manivannan J, et al. Reduced expression of MYC increases longevity and enhances healthspan. Cell. 2015;160(3):477-88.
97. Muzumdar R, Allison DB, Huffman DM, Ma X, Atzmon G, Einstein FH, et al. Visceral adipose tissue modulates mammalian longevity. Aging Cell. 2008;7(3):438-40.
98. Selman C, Withers DJ. Mammalian models of extended healthy lifespan. Philosophical Transactions of the Royal Society B: Biological Sciences. 2011;366(1561):99-107.
99. Liang H, Masoro EJ, Nelson JF, Strong R, McMahan CA, Richardson A. Genetic mouse models of extended lifespan. Exp Gerontol. 2003;38(11-12):1353-64.
100. Bost F, Aouadi M, Caron L, Even P, Belmonte N, Prot M, et al. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes. 2005;54(2):402-11.
101. Jiao P, Feng B, Li Y, He Q, Xu H. Hepatic ERK activity plays a role in energy metabolism. Molecular and Cellular Endocrinology. 2013;375(1-2):157-66.
102. Banks AS, McAllister FE, Camporez JP, Zushin PJ, Jurczak MJ, Laznik-Bogoslavski D, et al. An ERK/Cdk5 axis controls the diabetogenic actions of PPARgamma. Nature. 2015;517(7534):391-5.
103. Bi L, Chiang JY, Ding WX, Dunn W, Roberts B, Li T. Saturated fatty acids activate ERK signaling to downregulate hepatic sortilin 1 in obese and diabetic mice. Journal of Lipid Research. 2013;54(10):2754-62.